Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Neuroguy who wrote (1857)	2/28/1999 8:25:00 PM
From: Chuck Campbell	Read Replies (2) of 10280

Just a few points of clarification on the last 20 or so posts: 1) Sepracor is a chemistry based pharmaceutical company - not a biotech company. It is the first new fully integrated pharmaceutical company to enter the market in 30+ years. 2) Sepracor holds 25 patents & has 25 patents pending - 50, not 40. 3) Neuroguy, you are correct, the s isomer of Prozac is being studied for an entirely new disease state - the prevention of migraine. 4) Don't underestimate the marketing power of the partnering companies (ie - Lilly, J&J, Schering) when it comes to conversion of the original compound to the ICE. The combination of significant clinical benefits, strategic timing and strong sales & marketing makes for a powerful phenomenon. I've been a follower of this post for the last 9 months. I'm continually amazed by the overall accuracy of information that is presented. I hope I haven't overstepped my bounds by adding a little clarity. You've picked a long-term winner - keep the faith!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next